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Abstract
Background: Cervical cancer is the only gynaecological malignancy for which a screening modality is widely accepted and recom-
mended for all women.1 Just as in other developed countries, the decline in deaths from cervical cancer in the white population in 
South Africa after the mid-1960s has been attributed to cytological screening.2 The purpose of this study was to determine the extent 
of missed opportunities for cervical cancer screening by the healthcare service at Worcester Hospital and the closely associated 
Worcester Community Health Centre (CHC) for patients 30 years and older who presented at these centres for reasons unrelated to 
cervical cancer screening.  
Methods: A descriptive cross-sectional survey was conducted using a questionnaire that was administered through personal 
interviewing. A sample of 235 patients was selected from six sampling units. Sampling was done proportionately, according to the 
average numbers of patients normally seen daily at the various units.
Results: The mean age of the sample was 47, with 30 and 81 being the youngest and oldest patients respectively. The mean level 
of education for the sample was Grade 7 (Std 5). The overall rate for missed opportunities for cervical cancer screening was 93.2% 
(95% Confidence Interval (CI) 90%96%), as only 6.8% of patients were asked about cervical (Papanicolaou) smears during consulta-
tion. None of the patients that were seen at the medical, surgical and orthopaedic clinics and casualty were asked about whether they 
had had a cervical pap smear; 56.5% (95% CI 36%76%) of the patients that were seen at the gynaecology clinic were asked and 
2.3% (95% CI 0.3% 4.8%) from Worcester Community Health Centre were asked whether they had had a cervical smear. A total of 
15.7% [37/235: 95% CI 11%20%)] had never had a cervical smear, while 84.3% (198/235) had had a cervical smear previously. Of 
those who had had a cervical smear previously, 51% [101/198: (95% CI 44%58%)] had it performed at a local clinic, 40.4% [80/198: 
(95% CI 34%47%)] at a secondary hospital, 5.6% [11/198 (95%CI 2.3%8.7%)] privately and 3% [6/198: 995% CI 0.6%5.4%)] at a 
tertiary hospital.
Of those patients who had a smear done before (198), 52% [103/19852% (95% CI 45%59%)] were not given an appointment to 
return for the results, 32% (95% CI 25.8%38.8%) did not receive their results and 78.3% (95% CI 72.5%84.0%) were not advised on 
further management in the future. It is noteworthy that only 2.1% (5/235) of the patients had personally requested a cervical smear 
from a doctor at Worcester Hospital and Worcester CHC.
A total of 6.8% (16/235) patients were asked during the consultation whether they had had a cervical smear done before. On enquiry, 
a total of 99.2% (95% CI 97.9%100%) of the patients said that they would have preferred to have received information about a 
cervical smear from their doctor. 
Conclusion: Opportunities for cervical cancer screening were missed in patients attending Worcester Hospital and Worcester CHC. 
Women 30 years and older should routinely be asked about whether they are up to date with their cervical smears, irrespective of 
their presenting complaint. If they are found not to be up to date, they should have a cervical smear done or be referred appropriately 
to their clinics to have a cervical smear performed. When a smear has been done, a follow-up appointment should be made for them 
to be given the results, as well as advice regarding when the next smear is due. All such interactions between the patient and the 
healthcare worker should be clearly documented in the patient’s record. 
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Literature review
According to the World Health Organization (WHO), the incidence of 
cervical cancer is about four times greater in the developing world than 
elsewhere and industrialised countries have a low incidence, which is 
expected to decrease further due to screening.3
In South Africa, cancer of the cervix makes up 33% of all malignant 
tumours in black females. This is a deplorable situation, since it is 
a preventable condition, the incidence of which can be reduced by 
up to 90% through the use of a properly designed cervical cytology 
population screening programme.4 Between 1993 and 1995, an 
average of 3 387 new cases of cancer of the cervix were reported.5 
By contrast, 1 497 deaths from cancer of the cervix were reported by 
the Central Statistical Services (CSS) for 1994.5 The crude incidence 
rate was 17/100 000 and the age standardised incidence rate (ASIR) 
was 22/100 000.5 Cancer of the cervix was the second most common 
cancer in women, comprising 16.6% of all cancers.5 It is the most 
common cancer in black (31.2%) and coloured (22.9%) women, the 
second most common in Asian women (8.9%) and the fourth most 
common in white women (2.7%).3 The lifetime risk for all is one in 41.5 
Many studies done in South Africa show that there is a high prevalence 
of cervical carcinoma, particularly in the black communities.6–9 
Cervical cancer is the only gynaecological malignancy for which 
a screening modality is widely accepted and recommended for all 
women.1 Early detection of pre-cancerous lesions through cytological 
screening has been and most probably will remain the mainstay for 
global control of the disease for some time.10 Cervical smear screening 
with follow-up treatment of dysplastic lesions remains the best 
available method of reducing the mortality and incidence of cervical 
cancer.11 As in other developed countries, the decline in deaths from 
cervical cancer in the white population in South Africa after the mid-
1960s has been attributed to cytological screening.2 
While wide-scale cervical cancer screening has helped to decrease 
the incidence of the disease in developed countries, this has come at a 
massive cost, which appears prohibitive for developing countries with 
low-resource settings. There is increasing evidence in the literature 
to encourage new techniques as attractive alternatives to cervical 
screening in developing countries.12–20 However, Sawaya and Grimes, 
who caution about new technologies for cervical screening, warn 
that the shifting of resources for this purpose might cause net harm if 
the result is fewer screening opportunities for high-risk women. New 
screening technologies do not address the problem of the utilisation 
gap and might widen it by driving the cost of screening out of reach of 
high risk-women. Greater decreases in morbidity and mortality from 
cancer of the cervix would likely result if the same resources were 
invested in a comprehensive national screening programme that 
targeted women at highest risk.21
Studies reveal that cervical cancer screening and education in South 
Africa has been conducted on an opportunistic basis. This has 
resulted in multiple re-screening of a small proportion of the population 
at the exclusion of most women at high risk, and a low population 
coverage.2,22,23 Re-organising cervical screening programmes in 
the light of experiences from other countries and lessons from past 
failures, while also aiming for higher population coverage (> 80%), will 
help countries like South Africa to achieve better results in the control 
of cervical carcinoma.20 
There is evidence from the literature that there is a significantly high 
rate of missed opportunities for cervical screening. In one retrospective 
study, where the medical records of patients who had been diagnosed 
with invasive cervical cancer were examined up to about three years 
prior to the diagnosis of the disease, it was shown that 60% had not 
had a smear in the said period, and that 75% of these patients had 
had contact with the medical system, at least once, through clinics.24 
Another study showed that 65% of subjects with invasive cervical 
cancer had never had a pap smear until diagnosis, while 88% of them 
had seen a physician in the preceding three years.1,25
Yet another study, done in a low-income community, showed that 52% 
of new patients with invasive carcinoma of the cervix had no previous 
pap smear, while 62% of cases did not have a smear within five years 
prior to the diagnosis of the disease. In the five-year period before 
the diagnosis, it was shown that 73% of the unscreened women had 
received ambulatory medical care (including 41% who had regular care 
for chronic conditions), while 16% had been hospitalised.26
No figures relating to the incidence of missed opportunities are 
available for the Western Cape Province.27
It also emerges from the literature that there are four factors that 
contribute to the increased rate of missed opportunities for cervical 
screening, namely a combination of patient, provider, practice and 
access barriers. Patient and provider barriers represent human 
reasons or factors why both groups may be reluctant to participate 
in screening, while practice and access barriers exemplify systems 
factors that impede the screening process for both groups. Perceptions 
about these human and systems factors have been identified as 
reasons why the primary care providers may miss the opportunity to 
perform or recommend screening for their patients.28,29,30 However, 
it has been shown that the majority of the patients are receptive to 
cervical screening and that the most common reason for not having 
had a test was that they had never heard of it.31 This finding reveals the 
responsibility incumbent upon the doctors and the exceptional potential 
in each of their primary care consultations as healthcare providers to 
perform or at least recommend cervical screening.32 Seminars with 
experts in preventive care, guidelines and pamphlets have been found 
to be strategies to which many doctors are receptive and which would 
be most useful for improving cancer screening in general practice.33 
In this study, only the provider barrier factor was investigated. The 
published literature on missed opportunities for cervical screening is 
mainly from studies done on identified cases of cervical cancer. This 
study is different in that it targets the population at risk that is being 
missed by healthcare providers in our health facilities. It therefore does 
not focus on the records of identified cases of cervical cancer patients 
as a way of determining the rate of missed opportunities. The rate of 
missed opportunities for screening was determined from cases where 
screening was indicated but was not done or recommended by the 
doctor during the consultation.
This study therefore aimed to determine the proportions of missed 
opportunities regarding cervical screening for patients 30 years and 
older who attended the Worcester Hospital as well as the Worcester 
CHC for reasons unrelated to obtaining a cervical smear.
Methods
This was a descriptive cross-sectional survey using a questionnaire 
that was administered through personal interviewing. Following 
consultation with a statistician, a sample of 235 patients was selected 
from six sampling units. Sampling was done proportionately according 
to the average numbers of patients normally seen at the various units 
per day. A sampling unit was an individual clinic or a community health 
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centre. Systematic random sampling was used, in that every fifth 
patient seen by a doctor or nurse was included in the study.
Patients were selected from the following units, with the respective 
number of patients selected per unit in brackets.
1. Worcester Community Health Centre (133)
2. Orthopaedic clinic (26)
3. Casualty (39)
4. Gynaecological clinic (23)
5. Surgical clinic (7)
6. Medical clinic (7) 
 
A missed opportunity was defined as existing for a particular patient if 
all of the following criteria were present: intervention regarding cervical 
cancer screening was indicated, the patient was receptive to such 
intervention but did not receive such intervention or qualified for a 
cervical smear according to the South African Department of Health 
guidelines on cervical screening but did not have a cervical smear 
done, even if she presented with an unrelated clinical problem.
Patients were interviewed in private and the questionnaires, which 
were available in English, Afrikaans and Xhosa, were cross validated. 
Anonymity and confidentiality were maintained for all patients. The 
target population included all women 30 years and older attending 
Worcester Hospital and Worcester CHC. Patients under 30 years 
of age and those needing emergency care were excluded. Only 
those patients who actually consulted a doctor at these centres were 
included. The questionnaire was administered to the patients upon 
their exit from the clinic without the knowledge of the doctor and nurses 
working in the particular unit or clinic. The choice of an age cut-off 
of 30 years in this study was motivated by research studies, limited 
resources and the guidelines of the national policy of the Department 
of Health on cervical screening, which recommends three smears per 
lifetime, with a 10-year interval between each smear commencing at 
age 30.5,34–37
Informed consent was obtained from all the patients interviewed. 
The patients were assured of their anonymity, and formal consent to 
conduct the study was obtained from the superintendents of Worcester 
Hospital and Worcester CHC, as well as from the Department of 
Family Medicine and Primary Care. Ethics approval was granted 
by the Ethics Committee, Faculty of Health Sciences, University of 
Stellenbosch. The folders of all the patients were also audited for 
entries regarding cervical cancer screening interventions as a way of 
validating the responses of the patients. 
The questionnaire elicited the following information:
1. Demographic data.
2.  Language used during the consultation with the doctor and whether 
or not they were comfortable with it.
3.  Whether the doctor spoke to them about a cervical smear and 
whether they would have liked to have received such information 
from him/her.
4.  Whether they had had a cervical smear before and, if they had, to 
provide details about their last cervical smear regarding time, place, 
follow-up appointment, results and any advice given concerning 
further follow up in the future.
5.  Consent to do a cervical smear for those who had never had one 
and those whose last had been more than five years previously.
In cases where a missed opportunity for cervical screening was 
identified, a cervical smear was done immediately and a follow-up 
appointment was made for the results. Information leaflets were given 
to the patients for perusal at home. These were made available in 
English, Afrikaans and Xhosa and were obtained from the Cancer 
Association of South Africa and the Department of Health.
Statistical analysis
The results of the survey were analysed using the Microsoft Excel 
Programme.38 Categorical variables were compared by means of 
the chi-square test. P values of less than 0.05 were regarded as 
statistically significant. The formal assistance of a statistician was 
obtained and 95% confidence intervals were calculated for proportions 
and rounded off to the nearest integer.
Results
The mean age of the sample was 47, with the youngest and oldest 
patients being 30 and 81 respectively. The mean level of education for 
the sample was Grade 7 (Std 5). 
The overall prevalence rate for missed opportunities for cervical 
cancer screening was 93.2% (95% CI 90%–96%). The true missed 
rate, indicating those patients needing a cervical smear that were 
missed during consultation, was 46.8% (95% CI 38%–56%). None of 
the patients that were seen at the medical, surgical and orthopaedic 
clinics and casualty was asked about whether they had ever had a 
cervical smear, 56.5% (95% CI 36%–76%) of patients that were seen 
at the gynaecology clinic were asked, and 2.3% (95% CI 0.3%– 4.8%) 
at the Worcester CHC were asked whether they had had a cervical 
smear. A total of 15.7% patients [37/235: 95% CI 11%–20%)] had 
never had a cervical smear before and 84.3% (198/235) had a cervical 
smear performed previously. Of those who had a cervical smear done 
previously, 51% [101/198 (95% CI 44%–58%)] had it performed at 
a local clinic, 40.4% [80/198 (95% CI 34%–47%)] at a secondary 
hospital, 5.6% [11/198 (95%CI 2.3%–8.7%)] privately and 3% [6/198 
(95% CI 0.6%–5.4%)] at a tertiary hospital (see Figure 1).
Figure 1: Site where cervical smear was performed



















Of those patients who had a smear done before (198), 52% [103/
198–52% (95% CI 45%–59%)] were not given an appointment to 
return for the results, 32% (95% CI 25.8%–38.8%) did not get their 
results and 78.3% (95% CI 72.5%–84.0%) were not advised regarding 
further management. It is interesting to note that only 2.1% (5/235) of 
the patients had ever personally requested a cervical smear from a 
doctor at Worcester Hospital and Worcester CHC.
A total of 16 out of 235 patients were asked during the consultation 
whether they had a cervical smear done before. On enquiry, a total of 
99.2% (95% CI 97.9%–100%) of patients said that they would have 
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preferred to have received information about a cervical smear from 
their doctor. In 97.9% of cases [230/235 (95% CI: 96.0%–99.7%)], 
the record audit was consistent with the patient response during the 
interview. In 2.1% of cases (five cases: two at the Gynaecological clinic 
and three at the Worcester Community Health Centre), the patients 
reported that they were not asked about a cervical smear when the 
record audit revealed that the doctor had documented that the patient 
was asked about a cervical smear. 
A total of 44.6% [105/235 (95% CI 38.3%–51.0%)] had a pap smear 
done following the interview, while 11 patients could not have a 
cervical smear done immediately after the interview and were referred 
appropriately or a follow-up booking was made. A total of 72.6% 
[76/105 (95% CI 64.1%–81.1% )] had a normal cervical smear result, 
12.4% [13/105 (95% CI 6.1%–18.7%)] had a result showing infection 
or absent endocervical cells, 5.7% (6/105 (95% CI 1.3%–10.1%) had 
results showing atypical cell changes of unknown potential, 2.8% [3/
105 (95% CI 0.4%–6.0%)] had results showing cervical intraepithelial 
neoplasia stage I (CIN I), 2.8% [3/105 (95% CI 0.4%–6.0%)] had a 
result showing CIN II, 2.8% [3/105 (95% CI 0.4%–6.0% )] had a result 
showing CIN III and 0.95% [1/105 (95% CI 1.85%–2.8%)] had a result 
showing squamous cell carcinoma of the cervix (see Figure 2).















Cervical smear results for smears done after the interview
Discussion
There is a high rate of missed opportunities for cervical cancer 
screening in patients attending Worcester Hospital and Worcester 
Community Health Centre. Given the burden of the clinical problem of 
cervical cancer in developing countries, the widely acceptable nature 
of its screening modality and the availability of screening services and 
equipment, especially in South Africa, the failure of these facilities to 
utilise the opportunity provided them during consultation is a source 
of concern. Patients would benefit from at least enquiring from them 
about whether they are up to date with their cervical smears and 
recommending clinic attendance to them if a smear is indicated.
It is the burden of the disease on society, along with its possible effects 
on the whole patient, that should dictate the interactions between the 
clinician and the patient during the consultation, and not the interests 
of the clinician in a specific branch of medicine. The primary healthcare 
clinician serves a key role in prevention of disease and promotion of 
health, especially with regard to cervical screening.
Most cervical smears are performed at primary healthcare level. This 
finding is consistent with the widely acknowledged vital importance 
of the role played by primary healthcare in health promotion. If ever 
higher population coverage regarding cervical cancer screening is 
to be achieved, it will most likely be through the primary healthcare 
service. However, this study has shown that many patients who 
have cervical smears at the clinics concerned are not given follow-up 
appointments to obtain the results of their cervical smear. Patients 
may assume that the results of the cervical smear are normal if no 
further contact and arrangements for follow-up are made between 
them and the clinic. The service provision can therefore be improved 
through simply giving patients a follow-up date for their cervical smear 
results, written on their clinic card at the time when a cervical smear is 
performed.
It is important to note that, while the healthcare service may divide 
service delivery according to forms of disease and specialities of 
medicine, patients do not generally recognise those divisions. A 
significant 99.2% of the patients said that they would have liked to have 
received information about a cervical smear from their doctor during 
the consultation on the day of their visit. Furthermore, the index doctor 
might be the only doctor the patient will ever see before developing 
cervical carcinoma.
The following findings in this study remain cause for concern:
1.  All the patients seen at the medical, surgical and orthopaedic clinics 
and casualty were not asked about a cervical smear.
2.  Only 2.3% of the patients were asked about a cervical smear at 
Worcester CHC, a primary healthcare clinic.
3.  Only 2.1% of the patients had ever personally requested a cervical 
smear from a doctor at Worcester Hospital and Worcester CHC.
4.  A total of 52% of the patients who had cervical smears performed 
were not given follow-up appointments for their cervical smear 
results.
5.  A total of 32.3% of the patients who had cervical smears performed 
did not get their cervical smear results.
6.  A total of 15.7% of eligible patients had never had a cervical smear 
before.
7.  A total of 78.3% of the patients were not given any information 
regarding when their next cervical smear was due. 
8.  A total of 10% of the patients who had cervical smears performed 
after the interview had some form of cervical intraepithelial neoplasia 
Given the stated high prevalence of cervical intraepithelial neoplasia 
that was detected in this sample, every effort should be made to 
encourage regular cervical screening at primary care level, as well 
as making full use of the opportunities for cervical screening that are 
present at primary care level. It is at least encouraging to note that 
99.2% of the patients would have liked to have received information 
regarding cervical smears from their doctor. This indicates the 
willingness of the patients to receive instruction or education in this 
regard and points to an opportunity that is not adequately utilised.
The frequent changing of staff at Worcester Hospital and Worcester 
CHC results in a disturbing number of different doctors consulted 
at each visit. This leads to a lack of continuity of care and a poor 
doctor-patient relationship, which may be associated with missed 
opportunities.
The main recommendation arising from this study is that all women 30 
years and older should be routinely asked about whether their cervical 
smears are up to date and, if not, they should have one done or be 
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referred appropriately or advised and assisted in seeking help at their 
local clinic. When a smear has been done, a follow-up appointment 
should be made for the results to be provided and, upon giving the 
results, they should be given advice on when the next cervical smear 
will be due. Patients often have a high regard for any verbal advice 
from their doctor, and what the doctor does not emphasise during the 
consultation may be perceived as being unimportant. If the doctor does 
not talk about cervical screening to the patients, the patients may not 
be able to appreciate the value of this screening. Any advice given 
to a patient should be followed by clear documentation in the patient 
records.
It is hoped that the findings of this study will help healthcare workers 
(especially doctors) at the primary care level to appreciate the value of 
vigorous screening for cervical cancer as a doorway to early diagnosis 
and curative treatment of the most common cancer affecting the lives 
of women in their area of practice.
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